Patents by Inventor Michael L. Camilleri

Michael L. Camilleri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210072259
    Abstract: This document relates to methods and materials for assessing and/or treating obese mammals (e.g., obese humans). For example, methods and materials for using one or more interventions (e.g., one or more pharmacological interventions) to treat obesity and/or obesity-related comorbidities in a mammal (e.g., a human) identified as being likely to respond to a particular intervention (e.g., a pharmacological intervention) are provided.
    Type: Application
    Filed: November 21, 2018
    Publication date: March 11, 2021
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Andres J. Acosta, Michael L. Camilleri
  • Publication number: 20200330555
    Abstract: Provided herein are methods of treating or preventing gastrointestinal motility-related disorders, treating or preventing constipation or stimulating bowel function, comprising using variants and fusions of fibroblast growth factor 19 (FGF19), variants and fusions of fibroblast growth factor 21 (FGF21), fusions of FGF19 and/or FGF21, and variants or fusions of FGF19 and/or FGF21 proteins and peptide sequences (and peptidomimetics).
    Type: Application
    Filed: April 20, 2018
    Publication date: October 22, 2020
    Inventors: Stephen Joseph Rossi, Alexander Mark Deapoli, Michael L. Camilleri
  • Publication number: 20190145953
    Abstract: This document provides methods and materials involved in assessing intestinal permeability of a mammal. For example, methods and materials for administering 13C-mannitol to a mammal (e.g., a human) and determining urinary excretion of 13C-mannitol as a measure of intestinal permeability of a mammal are provided.
    Type: Application
    Filed: March 31, 2017
    Publication date: May 16, 2019
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Michael L. Camilleri, Madhusudan Grover, Ravinder J. Singh
  • Patent number: 8911393
    Abstract: A method and apparatus are disclosed for treating obesity includes an artificial fistula created between gastrointestinal organs such as between the stomach and the colon. The method includes selecting an implant comprising a passageway having an internal lumen with an inlet end and an outlet end. The passageway is positioned passing through a first wall of first gastrointestinal organ (for example, passing through the wall of the stomach) and a second wall of a second gastrointestinal organ (for example, passing through the wall of the large intestine) with the inlet end disposed within an interior of the first gastrointestinal organ and with the outlet disposed within an interior of the second gastrointestinal organ.
    Type: Grant
    Filed: February 6, 2013
    Date of Patent: December 16, 2014
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Michael J. Levy, Michael L. Camilleri, Joseph A. Murray, William J. Sandborn
  • Patent number: 8372158
    Abstract: A method and apparatus are disclosed for treating obesity includes an artificial fistula created between gastrointestinal organs such as between the stomach and the colon. The method includes selecting an implant comprising a passageway having an internal lumen with an inlet end and an outlet end. The passageway is positioned passing through a first wall of first gastrointestinal organ (for example, passing through the wall of the stomach) and a second wall of a second gastrointestinal organ (for example, passing through the wall of the large intestine) with the inlet end disposed within an interior of the first gastrointestinal organ and with the outlet disposed within an interior of the second gastrointestinal organ.
    Type: Grant
    Filed: September 22, 2010
    Date of Patent: February 12, 2013
    Assignee: EnteroMedics, Inc.
    Inventors: Michael J. Levy, Michael L. Camilleri, Joseph A. Murray, William J. Sandborn
  • Publication number: 20110268794
    Abstract: This document relates to methods and materials for administering bile acid compounds to treat conditions associated with constipation. For example, formulations designed for the delayed-release of a bile acid compound (e.g., sodium chenodeoxycholate) to treat constipation are provided.
    Type: Application
    Filed: January 4, 2010
    Publication date: November 3, 2011
    Inventors: Michael L. Camilleri, Duane D. Burton
  • Publication number: 20110038829
    Abstract: This document relates to methods and materials for administering bile acid sequestrants to treat conditions associated with diarrhea. For example, formulations designed for the delivery of a bile acid sequestrant (e.g., colesevelam) to treat diarrhea are provided.
    Type: Application
    Filed: August 5, 2010
    Publication date: February 17, 2011
    Applicant: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventor: Michael L. Camilleri
  • Publication number: 20110009980
    Abstract: A method and apparatus are disclosed for treating obesity includes an artificial fistula created between gastrointestinal organs such as between the stomach and the colon. The method includes selecting an implant comprising a passageway having an internal lumen with an inlet end and an outlet end. The passageway is positioned passing through a first wall of first gastrointestinal organ (for example, passing through the wall of the stomach) and a second wall of a second gastrointestinal organ (for example, passing through the wall of the large intestine) with the inlet end disposed within an interior of the first gastrointestinal organ and with the outlet disposed within an interior of the second gastrointestinal organ.
    Type: Application
    Filed: September 22, 2010
    Publication date: January 13, 2011
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Michael J. Levy, Michael L. Camilleri, Joseph A. Murray, William J. Sandborn
  • Patent number: 7803195
    Abstract: A method and apparatus are disclosed for treating obesity includes an artificial fistula created between gastrointestinal organs such as between the stomach and the colon. The method includes selecting an implant comprising a passageway having an internal lumen with an inlet end and an outlet end. The passageway is positioned passing through a first wall of first gastrointestinal organ (for example, passing through the wall of the stomach) and a second wall of a second gastrointestinal organ (for example, passing through the wall of the large intestine) with the inlet end disposed within an interior of the first gastrointestinal organ and with the outlet disposed within an interior of the second gastrointestinal organ.
    Type: Grant
    Filed: May 31, 2005
    Date of Patent: September 28, 2010
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Michael J. Levy, Michael L. Camilleri, Joseph A. Murray, William J. Sandborn
  • Publication number: 20100222228
    Abstract: The present invention relates generally to therapy and diagnosis of disorders associated with chronic visceral hypersensitivity (CVH), and in particular irritable bowel syndrome (IBS). In particular, this invention relates to the polypeptides as well as to the polynucleotides encoding these polypeptides, wherein said polypeptides are shown to be associated with CVH. These polypeptides and polynucleotides are useful in the diagnosis, treatment and/or prevention of disorders associated with CVH, in particular in the diagnosis, treatment and/or prevention of disorders associated with IBS.
    Type: Application
    Filed: October 11, 2007
    Publication date: September 2, 2010
    Applicants: JANSSEN PHARMACEUTICA N.V., MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Theodoor Victor Constant Thielemans, Jeroen Marcel Maria Roger Aerssens, Willem Jan-Paul Edmond Talloen, Leen Albert Leonarda Thielemans, Michael L. Camilleri
  • Publication number: 20030143548
    Abstract: Methods to predict a patient's responsiveness to 5-HT3 receptor antagonists are disclosed. The methods allow a clinician to predict a patient's responsiveness to 5-HT3 receptor antagonists by determining the correlation that exists between a genotype in the promoter region of the gene encoding a serotonin transporter protein and patient response to 5-HT3 receptor antagonist therapy. In addition, methods to treat patients suffering from diarrhea-predominant irritable bowel syndrome and methods to identify a patient population for inclusion in a 5-HT3 receptor antagonist clinical trial are disclosed.
    Type: Application
    Filed: January 28, 2002
    Publication date: July 31, 2003
    Inventors: Michael L. Camilleri, Raul A. Urrutia